Base de dados : MEDLINE
Pesquisa : C01.539.800.200.105 [Categoria DeCS]
Referências encontradas : 1240 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 124 ir para página                         

  1 / 1240 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28604330
[Au] Autor:Pupim ACE; Campois TG; Araújo EJA; Svidizinski TIE; Felipe I
[Ad] Endereço:1​Department of Pathological Sciences, Center for Biological Sciences, State University of Londrina, Rodovia Celso Garcia Cid km 380 - 86057-970, Londrina, PR, Brazil 2​Department of Histology, Center for Biological Sciences, State University of Londrina, Rodovia Celso Garcia Cid km 380 - 86057-
[Ti] Título:Infection and tissue repair of experimental cutaneous candidiasis in diabetic mice.
[So] Source:J Med Microbiol;66(6):808-815, 2017 Jun.
[Is] ISSN:1473-5644
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:PURPOSE: Diabetic patients seem to be predisposed to cutaneous candidiasis. In this study, we evaluated the interference of diabetic conditions in alloxan-induced diabetic mice in relation to the development of C. albicans infection, density of M1 and M2 macrophages, distribution of collagen type I and III and anti-inflamamatory cytokines involved in tissue repair. METHODOLOGY: The mice were treated with intravenous alloxan, and all animals with blood glucose levels >250 mg dl-1 were inoculate with C. albicans intradermally in the hind paw and were studied for up to 21 days. Control groups without alloxan were used. The fungal burden was evaluated by periodic acid-Schiff (PAS) and by counting the colony forming units. Total population of macrophages were targeted with antibody to F4/80 antigen and M2 macrophages with anti-arginase antibody. Anti-inflammatory cytokines from popliteal lymph nodes were determined by capture ELISA procedures. Picrosirius red staining allowed qunantification of collagen types I and III in the infected skin by using a polarized light microscope.Results/Key findings. Diabetic mice, versus non-diabetic mice, showed a significant lower density of F4/80 and M2 macrophages, higher fungal burden, deficiency in interleukin (IL)-4 production, and delayed IL-13 responses. The later clearance of C. albicans enhanced tissue injury, leading to a decrease in collagen type I. Moreover, collagen type III was increased by interference of IL-13 and transforming growth factor-ß cytokines. CONCLUSION: These findings highlight some important changes in diabetic animal responses to C. albicans infection that may be important to the pathophysiological processes underpinning cutaneous candidiasis in diabetic patients.
[Mh] Termos MeSH primário: Candidíase Cutânea/microbiologia
Candidíase Cutânea/fisiopatologia
Diabetes Mellitus Experimental/complicações
Cicatrização
[Mh] Termos MeSH secundário: Animais
Glicemia/análise
Candida albicans/crescimento & desenvolvimento
Candida albicans/imunologia
Candida albicans/fisiologia
Candidíase Cutânea/etiologia
Candidíase Cutânea/imunologia
Colágeno/análise
Citocinas/análise
Citocinas/imunologia
Diabetes Mellitus Experimental/imunologia
Diabetes Mellitus Experimental/fisiopatologia
Modelos Animais de Doenças
Interleucina-13/análise
Interleucina-4/análise
Macrófagos/imunologia
Masculino
Camundongos
Pele/química
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Blood Glucose); 0 (Cytokines); 0 (Interleukin-13); 207137-56-2 (Interleukin-4); 9007-34-5 (Collagen)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170726
[Lr] Data última revisão:
170726
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170613
[St] Status:MEDLINE
[do] DOI:10.1099/jmm.0.000496


  2 / 1240 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28420251
[Au] Autor:Cohen B
[Ad] Endereço:1 Johns Hopkins Children's Center, Baltimore, MD, USA.
[Ti] Título:Differential Diagnosis of Diaper Dermatitis.
[So] Source:Clin Pediatr (Phila);56(5_suppl):16S-22S, 2017 May.
[Is] ISSN:1938-2707
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Mild diaper dermatitis often occurs in children before toilet training is complete, particularly from 9 to 12 months of age, and the most common presentation is an irritant contact dermatitis. Diaper dermatitis may account for up to 25% of dermatology visits to health care providers during the first year of life. Fortunately, since the introduction of hypoallergenic, superabsorbent modern disposable diapers, the incidence and severity of irritant and allergic contact dermatitis has decreased dramatically. Diaper dermatitis broadly refers to skin disorders that occur in the diaper area, such as skin eruptions triggered by diapers, rashes exacerbated by the diaper, and other events that occur in the diaper area. A number of skin conditions that can occur anywhere on the skin may present with distinctive findings in the diaper area. The following discussion will review the most common triggers of diaper dermatitis and contact irritant dermatitis, while focusing on the skin conditions that may be associated or overlap clinically with contact dermatitis.
[Mh] Termos MeSH primário: Diagnóstico Diferencial
Dermatite das Fraldas/diagnóstico
[Mh] Termos MeSH secundário: Doença Aguda
Candidíase Cutânea/etiologia
Dermatite de Contato/etiologia
Dermatite das Fraldas/complicações
Dermatite das Fraldas/patologia
Fraldas Infantis
Equipamentos Descartáveis
Feminino
Seres Humanos
Lactente
Recém-Nascido
Ceratose Seborreica/patologia
Masculino
Infecções Cutâneas Estafilocócicas/etiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1705
[Cu] Atualização por classe:170504
[Lr] Data última revisão:
170504
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170420
[St] Status:MEDLINE
[do] DOI:10.1177/0009922817706982


  3 / 1240 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28040418
[Au] Autor:Kouara S; Ait Hlilou B; Abbadi A; Khalki H; Benbella I; Lahmadi K; Er-Rami M
[Ad] Endereço:Laboratoire de parasitologie-mycologie, hôpital militaire Moulay Ismaïl, boulevard Mohamed, El Hansali, Meknès 50000, Maroc. Electronic address: sarakouara7@gmail.com.
[Ti] Título:[Trichophyton tonsurans associated with non-albicans Candida species in hands onychomycosis about a Moroccan case].
[Ti] Título:Trichophyton tonsurans associé à Candida non albicans lors d'une onychomycose des mains, à propos d'un cas au Maroc..
[So] Source:J Mycol Med;27(1):119-123, 2017 Mar.
[Is] ISSN:1773-0449
[Cp] País de publicação:France
[La] Idioma:fre
[Ab] Resumo:INTRODUCTION: Trichophyton tonsurans is an anthropophilic dermatophyte, frequent in the USA and in Asia where it is responsible for causing tinea capitis. At present, we attend an emergence of this species in certain regions where it was not or little met. Here, we report a case of onychomycosis of the hand due to T. tonsurans associated with non-albicans Candida species at an adult woman. OBSERVATION: The patient is a 62-year-old woman, with hypertension and diabetes. She reports the rather frequent use of chemical cleaners for the housework. She presented one year previously a distal onycholysis of the last four fingers of the left hand. The clinical examination objectified a presence of intertrigo in the second interdigital space. The mycological examination showed at the direct examination mycelial elements and the culture allowed the isolation of T. tonsurans associated with non-albicans Candida species. DISCUSSION-CONCLUSION: Our observation highlights especially the identification of a species, which has been described only once in Morocco about a case with onychomycosis of the feet. A possible emergence of this species in our country is not far from being possible.
[Mh] Termos MeSH primário: Candidíase Cutânea/complicações
Dermatoses da Mão/diagnóstico
Onicomicose/diagnóstico
Tinha/complicações
[Mh] Termos MeSH secundário: Candida/isolamento & purificação
Candidíase Cutânea/diagnóstico
Feminino
Dermatoses da Mão/microbiologia
Seres Humanos
Intertrigo/diagnóstico
Intertrigo/microbiologia
Meia-Idade
Marrocos
Onicomicose/microbiologia
Tinha/diagnóstico
Trichophyton/isolamento & purificação
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171002
[Lr] Data última revisão:
171002
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170102
[St] Status:MEDLINE


  4 / 1240 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27807668
[Au] Autor:Jaworski R; Irga-Jaworska N; Naumiuk L; Chojnicki M; Haponiuk I
[Ad] Endereço:Department of Pediatric Cardiac Surgery, Copernicus Hospital in Gdansk, Al. Jana Pawla II 50, 80-462, Gdansk, Poland. radicis@go2.pl.
[Ti] Título:Fournier Gangrene Caused by Candida albicans in an Infant After Cardiac Surgery.
[So] Source:Mycopathologia;182(3-4):409-412, 2017 Apr.
[Is] ISSN:1573-0832
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:Fournier gangrene is a rare, rapidly progressive, life-threatening condition. We report a 23-day-old boy with pulmonary atresia and ventricular septal defect treated surgically, who developed Fournier gangrene. Emergency surgery was performed with tissue sampling for microbiological examination. Candida albicans was confirmed; caspofungin followed by fluconazole was administered with excellent results.
[Mh] Termos MeSH primário: Candida albicans/isolamento & purificação
Candidíase Cutânea/diagnóstico
Candidíase Cutânea/patologia
Gangrena de Fournier/etiologia
Gangrena de Fournier/patologia
Escroto/patologia
[Mh] Termos MeSH secundário: Antifúngicos/uso terapêutico
Candidíase Cutânea/tratamento farmacológico
Candidíase Cutânea/microbiologia
Equinocandinas/uso terapêutico
Fluconazol/uso terapêutico
Gangrena de Fournier/tratamento farmacológico
Seres Humanos
Recém-Nascido
Lipopeptídeos/uso terapêutico
Masculino
Escroto/microbiologia
Cirurgia Torácica
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antifungal Agents); 0 (Echinocandins); 0 (Lipopeptides); 8VZV102JFY (Fluconazole); F0XDI6ZL63 (caspofungin)
[Em] Mês de entrada:1704
[Cu] Atualização por classe:170414
[Lr] Data última revisão:
170414
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161104
[St] Status:MEDLINE
[do] DOI:10.1007/s11046-016-0086-4


  5 / 1240 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25902389
[Au] Autor:Zhang M; Chelnis J; Mawn LA
[Ad] Endereço:Vanderbilt Eye Institute, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A.
[Ti] Título:Periorbital Necrotizing Fasciitis Secondary to Candida parapsilosis and Streptococcus pyogenes.
[So] Source:Ophthal Plast Reconstr Surg;33(3S Suppl 1):S31-S33, 2017 May/Jun.
[Is] ISSN:1537-2677
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Necrotizing fasciitis is most often caused by either polymicrobial bacterial infections or by Gram-positive organisms, such as Streptococcus or Staphylococcus; however, rare cases of fungal necrotizing fasciitis have been reported. Candida parapsilosis is an emerging fungal pathogen. This fungus grows in either a yeast or pseudohyphal form. C. parapsilosis has been reported to cause keratitis, intraocular infection, and seeding of frontalis slings. C. parapsilosis is a commensal of human skin and can be acquired by nosocomial spread. Necrotizing fasciitis due to Candida has rarely been reported, but to date C. parapsilosis has not been identified as the causative organism in necrotizing fasciitis. This is the first documented case of human periocular soft tissue infection by C. parapsilosis, and also the first report providing evidence of mycotic infection in a necrotizing fasciitis concurrently infected by Streptococcus pyogenes.
[Mh] Termos MeSH primário: Candida/isolamento & purificação
Candidíase Cutânea/complicações
Infecções Oculares Bacterianas/etiologia
Fasciite Necrosante/etiologia
Doenças Orbitárias/etiologia
Infecções Estreptocócicas/etiologia
Streptococcus pyogenes/isolamento & purificação
[Mh] Termos MeSH secundário: Candidíase Cutânea/diagnóstico
Candidíase Cutânea/microbiologia
Infecção Hospitalar
Infecções Oculares Bacterianas/diagnóstico
Infecções Oculares Bacterianas/microbiologia
Fasciite Necrosante/diagnóstico
Fasciite Necrosante/microbiologia
Seres Humanos
Masculino
Meia-Idade
Doenças Orbitárias/diagnóstico
Doenças Orbitárias/microbiologia
Infecções Estreptocócicas/diagnóstico
Infecções Estreptocócicas/microbiologia
Tomografia Computadorizada por Raios X
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170901
[Lr] Data última revisão:
170901
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150423
[St] Status:MEDLINE
[do] DOI:10.1097/IOP.0000000000000476


  6 / 1240 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27920496
[Au] Autor:Hussain I; Hussain N; Manan A; Rashid A; Khan B; Bakhsh S
[Ad] Endereço:Department of Dermatology; Department of Pharmacy, SMBB Medical University, Larkana.
[Ti] Título:Fabrication of anti-vitiligo ointment containing : in vitro and in vivo characterization.
[So] Source:Drug Des Devel Ther;10:3805-3816, 2016.
[Is] ISSN:1177-8881
[Cp] País de publicação:New Zealand
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Vitiligo is a repugnant and odious dermatological malady of the time. It has an detrimental impact on the pigmentation of the human skin as a result of the destruction of cutaneous melanocytes. It affects 1%-2% of the population worldwide. Different therapeutic regimens have been deployed to treat vitiligo, but none of them could stand alone to be stated as a perfect cure. Recently, a change has been observed through novel experimental-designed optimization leading to the development of an anti-vitiligo ointment containing (PC) seed powder. AIM: The aim of this study was to explore the clinical outcomes of ointment containing powdered seeds of PC. MATERIALS AND METHODS: Guided by the protocol Response Surface Methodology, 13 formulations of concentration variance of permeation enhancers were prepared. The formulation fulfilling the required criteria (pH; temperature stability tests at 8°C±0.1°C, 25°C±0.1°C and 40°C±0.1°C; and the physical properties such as color, bleeding and rheology) was selected for clinical trials. Fourier transform infrared spectroscopy studies of seed powder of PC and selected formulation of the seed powder were performed. After obtaining informed consents and with prior approval of university and hospital ethical review boards, 20 patients (age range 25-65 years) were included in the present study. Formulations were applied on the affected body parts of patients, and some affected portion of the same patient was taken as control (self-control study design). The pigmentation of white spots of vitiligo was photographically evaluated before, during and after 12 weeks of treatment. Analysis of the measured values was performed using GraphPad Prism version 5 statistical software. A paired sample -test was performed to observe variation between repigmented patches and white patches of self-control. RESULTS: Hydrophilic ointment (10% w/w) prepared with seed powder of PC was fabricated. The ointment was found effective for small circular white lesions of vitiligo as compared to self-control. Pre- and post-treatment differences in the levels of pigmentation were statistically significant ( ≤0.05). CONCLUSION: Ointment containing seed powder of PC could be an effective monotherapy for small circular white lesions of vitiligo.
[Mh] Termos MeSH primário: Candidíase Cutânea/tratamento farmacológico
Candidíase Cutânea/fisiopatologia
Pomadas/farmacologia
Psoralea/química
Vitiligo/tratamento farmacológico
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Ointments)
[Em] Mês de entrada:1705
[Cu] Atualização por classe:170515
[Lr] Data última revisão:
170515
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161207
[St] Status:MEDLINE


  7 / 1240 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27572154
[Au] Autor:Rhew ZI; Han Y
[Ad] Endereço:Department of ImmunoMicrobiology, College of Pharmacy, Dongduk Women's University, 23-1 Wolgok-Dong, Sungbuk-Gu, Seoul, 136-714, Korea.
[Ti] Título:Synergic effect of combination of glycyrol and fluconazole against experimental cutaneous candidiasis due to Candida albicans.
[So] Source:Arch Pharm Res;39(10):1482-1489, 2016 Oct.
[Is] ISSN:0253-6269
[Cp] País de publicação:Korea (South)
[La] Idioma:eng
[Ab] Resumo:In this study, we investigated the anti-fungal activity of glycyrol, a coumarine isolated from licorice (Glycyrrhizae Radix), in a murine model of cutaneous candidiasis caused by Candida albicans. Compared to the infected sites, located on the mice's back, of the untreated control mice, the infected sites treated with glycyrol had reduced CFU (colony forming unit) values up to 60 and 85.5 % at 20 and 40 µg/mouse of glycyrol, respectively (P < 0.01). The antifungal activity of glycyrol was synergistically increased when glycyrol (10 µg/mouse) was combined with fluconazole (10 µg/mouse), demonstrating that the combination therapy is approximately 4 times more effective than fluconazole alone at 20 µg/mouse (P < 0.01). Additionally, the combination activity was 1.65 times greater than the antifungal activity of fluconazole alone at 40 µg/mouse (P < 0.05). In seeking glycyrol's antifungal mechanism, we determined that glycyrol inhibited hyphal induction and cell wall adherence of C. albicans. Thus, it is very likely that, by damaging the cell wall, glycyrol helps fluconazole invade C. albicans more readily and attack fluconazole's target in the fungus membrane. In summary, our data indicate that glycyrol may contribute to the development of a novel agent that possesses antifungal activity against cutaneous candidiasis.
[Mh] Termos MeSH primário: Antifúngicos/administração & dosagem
Candida albicans/efeitos dos fármacos
Candidíase Cutânea/tratamento farmacológico
Flavonoides/administração & dosagem
Fluconazol/administração & dosagem
[Mh] Termos MeSH secundário: Animais
Parede Celular/efeitos dos fármacos
Parede Celular/microbiologia
Sinergismo Farmacológico
Quimioterapia Combinada
Feminino
Camundongos
Camundongos Endogâmicos BALB C
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antifungal Agents); 0 (Flavonoids); 0 (glycyrol); 8VZV102JFY (Fluconazole)
[Em] Mês de entrada:1701
[Cu] Atualização por classe:170127
[Lr] Data última revisão:
170127
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160831
[St] Status:MEDLINE


  8 / 1240 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27516110
[Au] Autor:Chen KL; Chien MM; Chen CY; Chiu HC
[Ad] Endereço:Department of Dermatology, National Taiwan University Hospital, Taipei City, Taiwan.
[Ti] Título:Congenital cutaneous candidiasis.
[So] Source:BMJ Case Rep;2016, 2016 Aug 11.
[Is] ISSN:1757-790X
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Candidíase Cutânea/congênito
Candidíase/transmissão
Transmissão Vertical de Doença Infecciosa
Complicações Infecciosas na Gravidez/microbiologia
Doenças Vaginais/microbiologia
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Recém-Nascido
Masculino
Gravidez
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170223
[Lr] Data última revisão:
170223
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160813
[St] Status:MEDLINE


  9 / 1240 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27385469
[Au] Autor:Gassiep I; Douglas J; Playford EG
[Ad] Endereço:Department of Infectious Diseases, Princess Alexandra Hospital, Queensland Health, Woolloongabba, Queensland, Australia. ian.gassiep@gmail.com.
[Ti] Título:First report of monomicrobial Candida parapsilosis necrotizing fasciitis.
[So] Source:Transpl Infect Dis;18(5):752-755, 2016 Oct.
[Is] ISSN:1399-3062
[Cp] País de publicação:Denmark
[La] Idioma:eng
[Ab] Resumo:Candida parapsilosis is an emerging pathogen worldwide. It commonly causes soft tissue infection; however, to our knowledge there has been no previous report of monomicrobial necrotizing soft tissue infection (NSTI) secondary to C. parapsilosis. We report the first case of NSTI caused by C. parapsilosis in an immunocompromised renal transplant patient, with the diagnosis proven both histologically and microbiologically. Our patient required aggressive surgical intervention and antifungal therapy, with postoperative survival at 90 days.
[Mh] Termos MeSH primário: Antifúngicos/uso terapêutico
Candida/patogenicidade
Candidíase Cutânea/microbiologia
Fasciite Necrosante/microbiologia
Imunossupressão/efeitos adversos
Transplante de Rim/efeitos adversos
[Mh] Termos MeSH secundário: Amputação
Antifúngicos/administração & dosagem
Candida/isolamento & purificação
Equinocandinas/administração & dosagem
Equinocandinas/uso terapêutico
Fasciite Necrosante/patologia
Fasciite Necrosante/terapia
Fluconazol/administração & dosagem
Fluconazol/uso terapêutico
Seres Humanos
Hipertensão Renal/cirurgia
Hospedeiro Imunocomprometido
Perna (Membro)/cirurgia
Lipopeptídeos/administração & dosagem
Lipopeptídeos/uso terapêutico
Masculino
Meia-Idade
Nefrite/cirurgia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antifungal Agents); 0 (Echinocandins); 0 (Lipopeptides); 8VZV102JFY (Fluconazole); F0XDI6ZL63 (caspofungin)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160708
[St] Status:MEDLINE
[do] DOI:10.1111/tid.12571


  10 / 1240 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27337493
[Au] Autor:Mohammed YF; Salem EZ; Shahin IM; Abdo HM; Emam HE; Fawzy M; Abdel Salam MF
[Ad] Endereço:Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt. yaserclinic@yahoo.com.
[Ti] Título:Applicability of Fourier transform infrared (FTIR) spectroscopy in rapid identification of some Candida and dermatophyte species infections in humans.
[So] Source:Int J Dermatol;55(10):1164-71, 2016 Oct.
[Is] ISSN:1365-4632
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Traditional systems of identifying yeasts and dermatophytes have many disadvantages. Preliminary data on a radically different approach based on optical spectroscopic techniques suggest that these techniques may offer some advantages. We conducted a trial to verify the practical applicability of Fourier transform infrared (FTIR) spectroscopy in the identification of some yeast and dermatophyte species, in which samples from 50 patients with superficial fungal infections were cultured on Sabouraud dextrose agar with chloramphenicol and cycloheximide (actidione) and studied using FTIR microspectroscopy. Spectra of the same species were identical, whereas spectra of different species did not show similarity. This study showed that FTIR microspectroscopy is promising and can be used to obtain, with a single measurement, a "molecular fingerprint" of Candida and dermatophyte species. It can be improved further in terms of reliability.
[Mh] Termos MeSH primário: Candida albicans/isolamento & purificação
Dermatomicoses/diagnóstico
Dermatomicoses/microbiologia
Epidermophyton/isolamento & purificação
Microsporum/isolamento & purificação
Trichophyton/isolamento & purificação
[Mh] Termos MeSH secundário: Candidíase Cutânea/diagnóstico
Candidíase Cutânea/microbiologia
Seres Humanos
Espectroscopia de Infravermelho com Transformada de Fourier/métodos
Tinha/diagnóstico
Tinha/microbiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170626
[Lr] Data última revisão:
170626
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160624
[St] Status:MEDLINE
[do] DOI:10.1111/ijd.4957



página 1 de 124 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde